Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review.
Blauvelt A, Burge R, Malatestinic W, Brnabic A, Guo J, Janardhanan M, Zhu B.
Blauvelt A, et al. Among authors: brnabic a.
J Manag Care Spec Pharm. 2021 Jan;27(1):84-94. doi: 10.18553/jmcp.2021.27.1.084.
J Manag Care Spec Pharm. 2021.
PMID: 33377444
Free PMC article.
Assessing the cost of biologics relative to their cumulative clinical benefits versus a single time point represents an alternative to evaluate the value of a given biologic used to treat psoriasis. ...Burge, Zhu, Malatestinic, Brnabic, Guo, and Janardhanan a …
Assessing the cost of biologics relative to their cumulative clinical benefits versus a single time point represents an alternative t …